Know Cancer

or
forgot password

Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease


N/A
18 Years
N/A
Open (Enrolling)
Both
Lymphoma, Inflammatory Bowel Disease

Thank you

Trial Information

Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease


Inclusion Criteria:



- Inflammatory Bowel disease

- Lymphoma

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Retrospective

Principal Investigator

Michael V. Chiorean, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Indiana University

Authority:

United States: Institutional Review Board

Study ID:

060358

NCT ID:

NCT00577538

Start Date:

April 2006

Completion Date:

December 2007

Related Keywords:

  • Lymphoma
  • Inflammatory Bowel Disease
  • Inflammatory Bowel Diseases
  • Intestinal Diseases
  • Lymphoma
  • Lymphoproliferative Disorders

Name

Location

Indiana University Medical CenterIndianapolis, Indiana  46202